- Q1 2024 ReShape Lifesciences Inc Earnings Call TranscriptMay 15, 2024Earnings
- Q4 2023 ReShape Lifesciences Inc Earnings Call TranscriptApr 01, 2024Earnings
- Q3 2023 ReShape Lifesciences Inc Earnings Call TranscriptNov 08, 2023€0.615Earnings
- Q2 2023 ReShape Lifesciences Inc Earnings Call TranscriptAug 07, 2023€1.22 (-1.61%)Earnings
- ReShape Lifesciences Inc at OTC Markets Life Science Investor Forum TranscriptJun 22, 2023
- Q1 2023 ReShape Lifesciences Inc Earnings Call TranscriptMay 15, 2023€2.06 (-0.96%)Earnings
- Q4 2022 ReShape Lifesciences Inc Earnings Call TranscriptApr 25, 2023€2.26 (-3.42%)Earnings
- Q3 2022 ReShape Lifesciences Inc Earnings Call TranscriptNov 14, 2022€10.24 (-2.24%)Earnings
- Q2 2022 ReShape Lifesciences Inc Earnings Call TranscriptAug 15, 2022€23.93 (+7.87%)Earnings
- Q1 2022 ReShape Lifesciences Inc Earnings Call TranscriptMay 23, 2022€37.14 (-1.93%)Earnings
- Q4 2021 ReShape Lifesciences Inc Earnings Call TranscriptMar 28, 2022€62 (+3.77%)Earnings
- ReShape Lifesciences Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) TranscriptSep 20, 2021
- Q4 2019 Obalon Therapeutics Inc Earnings Call TranscriptFeb 27, 2020Earnings
- Q3 2019 Obalon Therapeutics Inc Earnings Call TranscriptNov 08, 2019Earnings
- Q2 2019 Obalon Therapeutics Inc Earnings Call TranscriptJul 24, 2019Earnings
- Q4 2018 Obalon Therapeutics Inc Earnings Call TranscriptFeb 22, 2019Earnings
Q4 2021 ReShape Lifesciences Inc Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the ReShape Lifesciences Fourth Quarter 2021 Earnings Conference Call. (Operator Instructions)
Please be advised that today's conference is being recorded. (Operator Instructions) I would now like to turn the conference over to your speaker for today, Michael Miller, Rx Communications. You may begin.
Good afternoon, and thank you for joining the Year-End 2021 ReShape Life Sciences Earnings Conference Call. I'm pleased to be joined by Bart Bandy, President and Chief Executive Officer of ReShape Lifesciences Inc, who will provide an overview of the company's activity during 2021 and milestones to date; Tom Stankovich, Chief Financial Officer of ReShape, will then review the financial results for the year, after which we will open up the call to a question-and-answer session.
As a reminder, this conference call, as well as ReShape Lifesciences' SEC
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)